Global Vaccine Cold Chain Logistics Market Size is valued at USD 3.5 Billion in 2024 and is predicted to reach USD 5.9 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034.
Technological advancements have helped in the development of vaccines in recent years. Vaccines are widely used to control infectious diseases as one of the prevention strategies to maintain the sustainable health of the population. The current covid-19 outbreak has significantly created a huge demand for temperature-controlled storage for vaccines across the globe.
Several drug candidates are being developed and tested to treat COVID-19 infection. There are currently over 250 vaccines across seven platforms being designed and trialed to treat COVID-19 infection. Few candidates are about to receive government approval or at the end of late-stage clinical trials of the Covid-19 vaccine in several countries. However, the next challenge that awaits is the cold chain logistics for vaccine distribution in various countries with different weather conditions. The proper cold storage is critical in the case of covid-19 vaccines as they require temperature-controlled storage and distribution to maintain their efficacy and other properties.
As per the white paper published by DHL in December 2020, around 200,000 pallet shipments and 15 million deliveries in cooling boxes, as well as 15,000 flights, will be required across various supply chain set-ups in the next two years to provide global coverage. Thus, the stable, safe, and IT-enabled supply chain framework and durable physical logistics infrastructure would help vaccine distribution globally.
In addition to the Covid-19 vaccine development, breakthroughs in cancer research efforts, growing pharmaceutical industry, augmented investment in R&D for vaccine development, and increased number of refrigerated warehouses are expected to boost the vaccine cold chain logistics market during the forecast period.
The Global Vaccine Cold Chain Logistics market is categorized based on services, packaging methods, mode of transportation, holding temperature range, and container and region.
On the basis of services, the market is segmented into storage, packaging, transportation. Based on packaging methods, the market is segmented into dry ice, liquid nitrogen, gel packs. on the basis of mode of transportation, the market is segregated into ground, air, and ocean. Based on the holding temperature range, the market is classified into vaccines requiring refrigerated temperature, vaccines requiring frozen temperature, vaccines requiring cryogenic temperature. On the basis of the containers, the market is segmented into active containers, passive containers.
Based on the region, the market is studied across North America, Asia-Pacific, Europe, and LAMEA. Among all, North America is expected to dominate the market during the forecast period.
| Report Attribute | Specifications |
| Market Size Value In 2024 | USD 3.5 Billion |
| Revenue Forecast In 2034 | USD 5.9 Billion |
| Growth Rate CAGR | CAGR of 5.3% from 2025 to 2034 |
| Quantitative Units | Representation of revenue in US$ Mn,and CAGR from 2025 to 2034 |
| Historic Year | 2021 to 2024 |
| Forecast Year | 2025-2034 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Service, By Packaging Method, By Mode of Transportation, By Holding Temperature Range, By Container |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Cryoport, DHL Express, GAC, Lynden International Logistics, PAREXEL, United Parcel Service, Yusen Logistics, DB Schenker, CEVA Logistics, Q1 Scientific, AmeriCold Logistics LLC, FedEx Corporation, Sofrigam, Sartorius AG, Intelsius, Envirotainer, Coldman Logistics, B Medical Systems, CSafe, Other Prominent Player |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Services, 2019-2030
Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Packaging Methods,
Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Mode of Transportation,
Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Holding Temperature Range,
Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Container,
Global Vaccine Cold Chain Logistics Market Revenue (US$ Mn), By Region,
North America Cold Chain Logistics Market Revenue (US$ Mn), by Country,
Europe Cold Chain Logistics Market Revenue (US$ Mn), by Country,
Asia Pacific Cold Chain Logistics Market Revenue (US$ Mn), by Country,
Latin America Cold Chain Logistics Market Revenue (US$ Mn), by Country,
Middle East & Africa Cold Chain Logistics Market Revenue (US$ Mn), by Country,
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.